Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Tomohiko Ishikawa, Toshinari Takahashi, Tetsuya Taniguchi & Tatsuo Hosoya. (2021) Dotinurad: a novel selective urate reabsorption inhibitor for the treatment of hyperuricemia and gout. Expert Opinion on Pharmacotherapy 22:11, pages 1397-1406.
Read now
Read now
Mizuki Yamane, Fumihiko Igarashi, Tsuyoshi Yamauchi & Toshito Nakagawa. (2021) Main contribution of UGT1A1 and CYP2C9 in the metabolism of UR-1102, a novel agent for the treatment of gout. Xenobiotica 51:1, pages 61-71.
Read now
Read now
Naoyuki Otani, Motoshi Ouchi, Hideo Kudo, Shuichi Tsuruoka, Ichiro Hisatome & Naohiko Anzai. (2020) Recent approaches to gout drug discovery: an update. Expert Opinion on Drug Discovery 15:8, pages 943-954.
Read now
Read now
Ying Pan & Ling-Dong Kong. (2016) Urate transporter URAT1 inhibitors: a patent review (2012 - 2015). Expert Opinion on Therapeutic Patents 26:10, pages 1129-1138.
Read now
Read now
Articles from other publishers (38)
Zhongqi Shi, Xueli Ge, Shuna Zheng, Pengjiao Zeng, Zhenguo Su, Xiulian Li & Jiayu Zhang. (2023) Mangiferin reduces uric acid via regulation of amino acid and lipid metabolism. Journal of Functional Foods 108, pages 105716.
Crossref
Crossref
Xiaoyu Cao, Jingyuan Cai, Yu Zhang, Chao Liu, Meijie Song, Qianqian Xu, Yang Liu & Hai Yan. (2023) Biodegradation of Uric Acid by Bacillus paramycoides-YC02. Microorganisms 11:8, pages 1989.
Crossref
Crossref
Emmanuel A. Adomako & Orson W. Moe. (2023) Uric acid transport, transporters, and their pharmacological targeting. Acta Physiologica 238:2.
Crossref
Crossref
Danni Song, Changqing Xie, Rong Yang, Aijinxiu Ma, Honghui Zhao, Fengmao Zou, Xiangrong Zhang & Xu Zhao. (2023) An application of citric acid as a carrier for solid dispersion to improve the dissolution and uric acid-lowering effect of kaempferol. International Journal of Food Engineering 19:1-2, pages 49-60.
Crossref
Crossref
Peng Zhang, Zhengqiang Jiang, Jia Lei, Qiaojuan Yan & Chang Chang. (2023) Novel hemoglobin-derived xanthine oxidase inhibitory peptides: Enzymatic preparation and inhibition mechanisms. Journal of Functional Foods 102, pages 105459.
Crossref
Crossref
Jia-jun Luo, Xin-hua Chen, Peng-ying Liang, Zean Zhao, Ting Wu, Zhong-huang Li, Shan-he Wan, Jian Luo, Jian-xin Pang, Jia-jie Zhang & Yuan-xin Tian. (2023) Mechanism of anti-hyperuricemia of isobavachin based on network pharmacology and molecular docking. Computers in Biology and Medicine 155, pages 106637.
Crossref
Crossref
Reeta James & Binoy J. Paul. (2023) New and emerging therapies in gout. Rheumatology & Autoimmunity.
Crossref
Crossref
Zhenjie Mao, Hong Jiang & Xiangzhao Mao. (2023) Identification and Anti-Hyperuricemic Activity of Xanthine Oxidase Inhibitory Peptides from Pacific White Shrimp and Swimming Crab Based on Molecular Docking Screening. Journal of Agricultural and Food Chemistry 71:3, pages 1620-1627.
Crossref
Crossref
Xiaoyu Zi, Xi Zhang, Chuan Hao & Zhenxing Wang. (2023) Risk factors and management of hyperuricemia after renal transplantation. Frontiers in Surgery 9.
Crossref
Crossref
玉珩 李. (2023) Research Progress of Traditional Chinese and Western Medicine on Hyperuricemia. Advances in Clinical Medicine 13:09, pages 14901-14907.
Crossref
Crossref
Ya-Jia Li, Li-Rong Chen, Zhong-Lei Yang, Ping Wang, Fang-Fang Jiang, Yu Guo, Kai Qian, Mei Yang, Sun-Jun Yin & Gong-Hao He. (2022) Comparative efficacy and safety of uricosuric agents in the treatment of gout or hyperuricemia: a systematic review and network meta-analysis. Clinical Rheumatology 42:1, pages 215-224.
Crossref
Crossref
Yajun Yang, Dingan Yan, Hanzeng Cheng, Guanglei Nan, Xianxin Hou, Long Ren, Ying Yang, Xuechen Li, Jinying Tian, Fei Ye & Zhiyan Xiao. (2022) Discovery of novel 1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors with hypouricemic effects. Bioorganic Chemistry 129, pages 106162.
Crossref
Crossref
Lei Zhao, Xin Ai, Fei Pan, Na Zhou, Liang Zhao, Shengbao Cai & Xiaoning Tang. (2022) Novel peptides with xanthine oxidase inhibitory activity identified from macadamia nuts: integrated in silico and in vitro analysis. European Food Research and Technology 248:8, pages 2031-2042.
Crossref
Crossref
Baixi Shan, Ting Chen, Bixia Huang, Yang Liu & Jun Chen. (2021) Untargeted metabolomics reveal the therapeutic effects of Ermiao wan categorized formulas on rats with hyperuricemia. Journal of Ethnopharmacology 281, pages 114545.
Crossref
Crossref
Jinfen Chen, Lieqiang Xu, Linyun Jiang, Yulin Wu, Long Wei, Xiaoli Wu, Shihong Xiao, Yuhong Liu, Changjun Gao, Jian Cai & Ziren Su. (2021)
Sonneratia apetala
seed oil attenuates potassium oxonate/hypoxanthine-induced hyperuricemia and renal injury in mice
. Food & Function 12:19, pages 9416-9431.
Crossref
Crossref
Tao Han Lee, Jia-Jin Chen, Chao-Yi Wu, Chih-Wei Yang & Huang-Yu Yang. (2021) Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy. Diagnostics 11:9, pages 1674.
Crossref
Crossref
Danni Song, Xu Zhao, Fuqi Wang & Gang Wang. (2021) A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications. European Journal of Pharmacology 907, pages 174291.
Crossref
Crossref
Haiyan Zhou, Guorui Zhong, Jing Bai, Xiaolei Li, Wen Peng, Lei Zhang & Jing Li. (2021) Development of a fluorescence-based assay for screening of urate transporter 1 inhibitors using 6-carboxyfluorescein. Analytical Biochemistry 626, pages 114246.
Crossref
Crossref
Hao-lu Sun, Yi-wan Wu, He-ge Bian, Hui Yang, Heng Wang, Xiao-ming Meng & Juan Jin. (2021) Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia. Frontiers in Pharmacology 12.
Crossref
Crossref
Chen Sun, Mingyu Zhang, Yanhong Zhao, Jianxin Pang, Ying Peng & Jiang Zheng. (2020) An LC-MS/MS- and hURAT1 cell-based approach for screening of uricosuric agents. Journal of Chromatography B 1159, pages 122336.
Crossref
Crossref
Tong Zhao, Qing Meng, Zhuosen Sun, Yanyu Chen, Wei Ai, Zean Zhao, Dongwei Kang, Yue Dong, Ruipeng Liang, Ting Wu, Jianxin Pang, Xinyong Liu & Peng Zhan. (2020) Novel Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Favorable Druggability. Journal of Medicinal Chemistry 63:19, pages 10829-10854.
Crossref
Crossref
Xiao-Yun Xiong, Jun Liang, Sheng-Ya Guo, Ming-Zhu Dai, Jia-Li Zhou, Yong Zhang & Yi Liu. (2020) A natural complex product Yaocha reduces uric acid level in a live zebrafish model. Journal of Pharmacological and Toxicological Methods 102, pages 106681.
Crossref
Crossref
Xin Zhang, Dapeng Wan, Guosheng Yang, Qingping Peng & Xiaohui Wang. (2019) Febuxostat is superior to allopurinol in delaying the progression of renal impairment in patients with chronic kidney disease and hyperuricemia. International Urology and Nephrology 51:12, pages 2273-2283.
Crossref
Crossref
Shuangshuang Zhang, Yong Wang, Jinsong Cheng, Ning Huangfu, Ruochi Zhao, Zhenyu Xu, Fuxing Zhang, Wenyuan Zheng & Dandan Zhang. (2019) Hyperuricemia and Cardiovascular Disease. Current Pharmaceutical Design 25:6, pages 700-709.
Crossref
Crossref
Weiwei He, Guowan Su, Dongxiao Sun-Waterhouse, Geoffrey I.N. Waterhouse, Mouming Zhao & Yang Liu. (2019) In vivo anti-hyperuricemic and xanthine oxidase inhibitory properties of tuna protein hydrolysates and its isolated fractions. Food Chemistry 272, pages 453-461.
Crossref
Crossref
Caroline L. Benn, Pinky Dua, Rachel Gurrell, Peter Loudon, Andrew Pike, R. Ian Storer & Ciara Vangjeli. (2018) Physiology of Hyperuricemia and Urate-Lowering Treatments. Frontiers in Medicine 5.
Crossref
Crossref
Danling Liang, Tianqiao Yong, Shaodan Chen, Yizhen Xie, Diling Chen, Xinxin Zhou, Dan Li, Muxia Li, Lu Su & Dan Zuo. (2018) Hypouricemic Effect of 2,5-Dihydroxyacetophenone, a Computational Screened Bioactive Compound from Ganoderma applanatum, on Hyperuricemic Mice. International Journal of Molecular Sciences 19:5, pages 1394.
Crossref
Crossref
Qibiao Su, Hua Su, Zhihuan Nong, Dongmei Li, Laiyou Wang, Shifeng Chu, Lizhen Liao, Jie Zhao, Xianbiao Zeng, Qikang Ya, Fei He, Wenjie Lu, Baowei Wei, Guining Wei & Naihong Chen. (2018) Hypouricemic and Nephroprotective Effects of an Active Fraction from <b><i>Polyrhachis Vicina Roger</i></b> On Potassium Oxonate-Induced Hyperuricemia in Rats. Kidney and Blood Pressure Research 43:1, pages 220-233.
Crossref
Crossref
Xiaokui Huo & Kexin Liu. (2018) Renal organic anion transporters in drug–drug interactions and diseases. European Journal of Pharmaceutical Sciences 112, pages 8-19.
Crossref
Crossref
Ting Wu, Jiasheng Chen, Shuai Dong, Haixin Li, Ying Cao, Yuanxin Tian, Weimin Fu, Pingzheng Zhou, Baomin Xi & Jianxin Pang. (2017) Identification and characterization of a potent and selective inhibitor of human urate transporter 1. Pharmacological Reports 69:5, pages 1103-1112.
Crossref
Crossref
Jianfei Wang, Wenqin Zeng, Shaohua Li, Liang Shen, Zhengxian Gu, Yang Zhang, Jian Li, Shuhui Chen & Xiangbo Jia. (2017) Discovery and Assessment of Atropisomers of (±)-Lesinurad. ACS Medicinal Chemistry Letters 8:3, pages 299-303.
Crossref
Crossref
Wenqing Cai, Wei Liu, Yafei Xie, Jingwei Wu, Yuqiang Liu, Changying Liu, Weiren Xu, Lida Tang, Jianwu Wang & Guilong Zhao. (2017) Design, synthesis and biological activity of tetrazole-bearing uric acid transporter 1 inhibitors. Chemical Research in Chinese Universities 33:1, pages 49-60.
Crossref
Crossref
Jasvinder A. Singh. (2016) Gout: will the ?King of Diseases? be the first rheumatic disease to be cured?. BMC Medicine 14:1.
Crossref
Crossref
He Tian, Wei Liu, Zhixing Zhou, Qian Shang, Yuqiang Liu, Yafei Xie, Changying Liu, Weiren Xu, Lida Tang, Jianwu Wang & Guilong Zhao. (2016) Discovery of a Flexible Triazolylbutanoic Acid as a Highly Potent Uric Acid Transporter 1 (URAT1) Inhibitor. Molecules 21:11, pages 1543.
Crossref
Crossref
R. Ian Storer, Robert M. Owen, Andy Pike, Caroline L. Benn, Emma Armstrong, David C. Blakemore, Magda Bictash, Kathryn Costelloe, Emma Impey, Philip H. Milliken, Elisabeth Mortimer-Cassen, Hannah J. Pearce, Benjamin Pibworth & Gianna Toschi. (2016) The discovery and evaluation of diaryl ether heterocyclic sulfonamides as URAT1 inhibitors for the treatment of gout. MedChemComm 7:8, pages 1587-1595.
Crossref
Crossref
Jiao Chen, Jia Zhou, Shuangshuang Wei, Zhijun Xie, Chengping Wen & Guowang Xu. (2016) Effect of a traditional Chinese medicine prescription Quzhuotongbi decoction on hyperuricemia model rats studied by using serum metabolomics based on gas chromatography–mass spectrometry. Journal of Chromatography B 1026, pages 272-278.
Crossref
Crossref
S. O. Ahn, S. Ohtomo, J. Kiyokawa, T. Nakagawa, M. Yamane, K. J. Lee, K. H. Kim, B. H. Kim, J. Tanaka, Y. Kawabe & N. Horiba. (2016) Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone. Journal of Pharmacology and Experimental Therapeutics 357:1, pages 157-166.
Crossref
Crossref
Andy Pike, R. Ian Storer, Robert M. Owen, Emma Armstrong, Caroline L. Benn, Magda Bictash, Kathy F. K. Cheung, Kathryn Costelloe, Emmanuel Dardennes, Emma Impey, Philip H. Milliken, Elisabeth Mortimer-Cassen & Hannah J. Pearce. (2016) The design, synthesis and evaluation of low molecular weight acidic sulfonamides as URAT1 inhibitors for the treatment of gout. MedChemComm 7:8, pages 1572-1579.
Crossref
Crossref